273 related articles for article (PubMed ID: 31077988)
21. G-protein-coupled receptors in drug discovery: nanosizing using cell-free technologies and molecular biology approaches.
Leifert WR; Aloia AL; Bucco O; Glatz RV; McMurchie EJ
J Biomol Screen; 2005 Dec; 10(8):765-79. PubMed ID: 16234342
[TBL] [Abstract][Full Text] [Related]
22. Multidimensional GPCR profiling and screening using impedance-based label-free and real-time assay.
Ke N; Nguyen K; Irelan J; Abassi YA
Methods Mol Biol; 2015; 1272():215-26. PubMed ID: 25563187
[TBL] [Abstract][Full Text] [Related]
23. Fragment-based lead discovery on G-protein-coupled receptors.
Visegrády A; Keserű GM
Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
[TBL] [Abstract][Full Text] [Related]
24. Evaluating cellular impedance assays for detection of GPCR pleiotropic signaling and functional selectivity.
Peters MF; Scott CW
J Biomol Screen; 2009 Mar; 14(3):246-55. PubMed ID: 19211780
[TBL] [Abstract][Full Text] [Related]
25. Biasing GPCR signaling from inside.
Shukla AK
Sci Signal; 2014 Jan; 7(310):pe3. PubMed ID: 24473194
[TBL] [Abstract][Full Text] [Related]
26. Resonant waveguide grating biosensor for whole-cell GPCR assays.
Fang Y; Ferrie AM; Tran E
Methods Mol Biol; 2009; 552():239-52. PubMed ID: 19513654
[TBL] [Abstract][Full Text] [Related]
27. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
Heilker R; Wolff M; Tautermann CS; Bieler M
Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
[TBL] [Abstract][Full Text] [Related]
28. Label-free impedance measurements to unravel biomolecular interactions involved in G protein-coupled receptor signaling.
Skiba M; Stolwijk JA; Wegener J
Methods Cell Biol; 2022; 169():221-236. PubMed ID: 35623703
[TBL] [Abstract][Full Text] [Related]
29. Nomad Biosensors: A New Multiplexed Technology for the Screening of GPCR Ligands.
Mella RM; Kortazar D; Roura-Ferrer M; Salado C; Valcárcel M; Castilla A; Villacé P
SLAS Technol; 2018 Jun; 23(3):207-216. PubMed ID: 29412765
[TBL] [Abstract][Full Text] [Related]
30. Detection and quantification of allosteric modulation of endogenous m4 muscarinic acetylcholine receptor using impedance-based label-free technology in a neuronal cell line.
Chen AN; Malone DT; Pabreja K; Sexton PM; Christopoulos A; Canals M
J Biomol Screen; 2015 Jun; 20(5):646-54. PubMed ID: 25534830
[TBL] [Abstract][Full Text] [Related]
31. Label-Free Dynamic Mass Redistribution and Bio-Impedance Methods for Drug Discovery.
Grundmann M
Curr Protoc Pharmacol; 2017 Jun; 77():9.24.1-9.24.21. PubMed ID: 28640952
[TBL] [Abstract][Full Text] [Related]
32. Tango assay for ligand-induced GPCR-β-arrestin2 interaction: Application in drug discovery.
Dogra S; Sona C; Kumar A; Yadav PN
Methods Cell Biol; 2016; 132():233-54. PubMed ID: 26928547
[TBL] [Abstract][Full Text] [Related]
33. Yeast system as a screening tool for pharmacological assessment of g protein coupled receptors.
Minic J; Sautel M; Salesse R; Pajot-Augy E
Curr Med Chem; 2005; 12(8):961-9. PubMed ID: 15853708
[TBL] [Abstract][Full Text] [Related]
34. Constitutive activity of the metabotropic glutamate receptor 2 explored with a whole-cell label-free biosensor.
Doornbos MLJ; Van der Linden I; Vereyken L; Tresadern G; IJzerman AP; Lavreysen H; Heitman LH
Biochem Pharmacol; 2018 Jun; 152():201-210. PubMed ID: 29605627
[TBL] [Abstract][Full Text] [Related]
35. High content screening for G protein-coupled receptors using cell-based protein translocation assays.
Grånäs C; Lundholt BK; Heydorn A; Linde V; Pedersen HC; Krog-Jensen C; Rosenkilde MM; Pagliaro L
Comb Chem High Throughput Screen; 2005 Jun; 8(4):301-9. PubMed ID: 16101006
[TBL] [Abstract][Full Text] [Related]
36. Functional assays for screening GPCR targets.
Thomsen W; Frazer J; Unett D
Curr Opin Biotechnol; 2005 Dec; 16(6):655-65. PubMed ID: 16257523
[TBL] [Abstract][Full Text] [Related]
37. Nanobodies as sensors of GPCR activation and signaling.
El Daibani A; Che T
Methods Cell Biol; 2021; 166():161-177. PubMed ID: 34752331
[TBL] [Abstract][Full Text] [Related]
38. Strategies for the discovery of biased GPCR ligands.
Bermudez M; Nguyen TN; Omieczynski C; Wolber G
Drug Discov Today; 2019 Apr; 24(4):1031-1037. PubMed ID: 30831262
[TBL] [Abstract][Full Text] [Related]
39. Advances in G protein-coupled receptor high-throughput screening.
Yasi EA; Kruyer NS; Peralta-Yahya P
Curr Opin Biotechnol; 2020 Aug; 64():210-217. PubMed ID: 32653805
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
Kristiansen K
Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
